Fecal urgency and incontinence in inflammatory bowel disease perceived by physician and patient: Results from the Swiss fecal urgency survey.
Crohn's disease
fecal incontinence
fecal urgency
inflammatory bowel disease
ulcerative colitis
Journal
United European gastroenterology journal
ISSN: 2050-6414
Titre abrégé: United European Gastroenterol J
Pays: England
ID NLM: 101606807
Informations de publication
Date de publication:
08 Sep 2024
08 Sep 2024
Historique:
received:
09
05
2024
accepted:
06
08
2024
medline:
9
9
2024
pubmed:
9
9
2024
entrez:
9
9
2024
Statut:
aheadofprint
Résumé
Although increasingly appreciated, little is known about the prevalence of fecal urgency, fecal incontinence and differences between patients' and physicians' perception in inflammatory bowel disease (IBD). We performed an online patient and physician survey to evaluate the assessment, prevalence and impact of fecal urgency and incontinence in IBD. A total of 593 patients (44.0% ulcerative colitis (UC), 53.5% Crohn's disease (CD), 2.2% indeterminate colitis, 2 not specified) completed the survey (65.8% females, mean age 47.1 years). Fecal urgency was often reported (UC: 98.5%, CD: 96.2%) and was prevalent even during remission (UC: 65.9%, CD: 68.5%). Fecal urgency considerably impacted daily activities (visual analog scale [VAS] 5, IQR 3-8). Yet, 22.8% of patients have never discussed fecal urgency with their physicians. Fecal incontinence was experienced by 44.7% of patients and 7.9% on a weekly basis. Diapers/pads were required at least once a month in 20.4% of patients. However, 29.7% of patients never talked with their physician about fecal incontinence. UC was an independent predictor for the presence of moderate-severe fecal urgency (OR 1.65, 95% CI 1.13-2.41) and fecal incontinence (OR 1.77, 95% CI 1.22-2.59). All physicians claimed to regularly inquire about fecal urgency and incontinence. However, the impact of these symptoms on daily activities was overestimated compared with the patient feedback (median VAS 8 vs. 5, p = 0.0113, and 9 vs. 5, p = 0.0187). Fecal urgency and incontinence are burdensome symptoms in IBD, with a similar prevalence in UC and CD. A mismatch was found between the physician and patient perception. These symptoms should be addressed during outpatient visits.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Swiss National Science Foundation
ID : P2ZHP3_168561
Pays : Switzerland
Organisme : Swiss Society of Gastroenterology
Organisme : Novartis Foundation for Medical-Biological Research
Informations de copyright
© 2024 The Author(s). United European Gastroenterology Journal published by Wiley Periodicals LLC on behalf of United European Gastroenterology.
Références
Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med. 2009;361(21):2066–2078. https://doi.org/10.1056/nejmra0804647
Dubinsky M, Bleakman AP, Panaccione R, Hibi T, Schreiber S, Rubin D, et al. Bowel urgency in ulcerative colitis: current perspectives and future directions. Am J Gastroenterol. 2023;118(11):1940–1953. https://doi.org/10.14309/ajg.0000000000002404
Saldana Ruiz N, Kaiser AM. Fecal incontinence ‐ challenges and solutions. World J Gastroenterol. 2017;23(1):11–24. https://doi.org/10.3748/wjg.v23.i1.11
Caron B, Ghosh S, Danese S, Peyrin‐Biroulet L. Identifying, understanding, and managing fecal urgency in inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2023;21(6):1403–1413. https://doi.org/10.1016/j.cgh.2023.02.029
Loening‐Baucke V, Metcalf AM, Shirazi S. Anorectal manometry in active and quiescent ulcerative colitis. Am J Gastroenterol. 1989;84(8):892–897.
Papathanasopoulos A, Van Oudenhove L, Katsanos K, Christodoulou D, Tack J, Tsianos EV. Severity of fecal urgency and incontinence in inflammatory bowel disease: clinical, manometric and sonographic predictors. Inflamm Bowel Dis. 2013;19(11):2450–2456. https://doi.org/10.1097/mib.0b013e3182a2952b
Newton L, Randall JA, Hunter T, Keith S, Symonds T, Secrest RJ, et al. A qualitative study exploring the health‐related quality of life and symptomatic experiences of adults and adolescents with ulcerative colitis. J Patient Rep Outcomes. 2019;3(1):66. https://doi.org/10.1186/s41687‐019‐0154‐x
Gu P, Kuenzig ME, Kaplan GG, Pimentel M, Rezaie A. Fecal incontinence in inflammatory bowel disease: a systematic review and meta‐analysis. Inflamm Bowel Dis. 2018;24(6):1280–1290. https://doi.org/10.1093/ibd/izx109
Leigh RJ, Turnberg LA. Faecal incontinence: the unvoiced symptom. Lancet. 1982;1(8285):1349–1351. https://doi.org/10.1016/s0140‐6736(82)92413‐8
Bartlett L, Nowak M, Ho YH. Reasons for non‐disclosure of faecal incontinence: a comparison between two survey methods. Tech Coloproctol. 2007;11(3):251–257. https://doi.org/10.1007/s10151‐007‐0360‐z
Aitola P, Lehto K, Fonsell R, Huhtala H. Prevalence of faecal incontinence in adults aged 30 years or more in general population. Colorectal Dis. 2010;12(7):687–691. https://doi.org/10.1111/j.1463‐1318.2009.01878.x
Rubin DT, Sninsky C, Siegmund B, Sans M, Hart A, Bressler B, et al. International perspectives on management of inflammatory bowel disease: opinion differences and similarities between patients and physicians from the IBD GAPPS survey. Inflamm Bowel Dis. 2021;27(12):1942–1953. https://doi.org/10.1093/ibd/izab006
Nigam GB, Limdi JK, Bate S, Hamdy S, Vasant DH. Fecal urgency in ulcerative colitis: impact on quality of life and psychological well‐being in active and inactive disease states. Clin Gastroenterol Hepatol. 2023. Epub ahead of print.
D'Haens G, Dubinsky M, Kobayashi T, Irving PM, Howaldt S, Pokrotnieks J, et al. Mirikizumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2023;388(26):2444–2455. https://doi.org/10.1056/nejmoa2207940
Marín‐Jiménez I, Gobbo Montoya M, Panadero A, Cañas M, Modino Y, Romero de Santos C, et al. Management of the psychological impact of inflammatory bowel disease: perspective of doctors and patients‐the ENMENTE project. Inflamm Bowel Dis. 2017;23(9):1492–1498. https://doi.org/10.1097/mib.0000000000001205
Dawwas GK, Jajeh H, Shan M, Naegeli AN, Hunter T, Lewis JD. Prevalence and factors associated with fecal urgency among patients with ulcerative colitis and Crohn's disease in the study of a prospective adult research cohort with inflammatory bowel disease. Crohns Colitis 360. 2021;3(3):otab046. https://doi.org/10.1093/crocol/otab046
Nóbrega VG, Silva INN, Brito BS, Silva J, Silva MCMD, Santana GO. The onset of clinical manifestations in inflammatory bowel disease patients. Arq Gastroenterol. 2018;55(3):290–295. https://doi.org/10.1590/s0004‐2803.201800000‐73
Schreiber S, Travis S, Potts Bleakman A, Kayhan C, Ellis H, Hunter T, et al. Communicating needs and features of IBD experiences (CONFIDE) survey; Burden and impact of bowel urgency on patients with moderate to severe ulcerative colitis. Gastroenterology. 2022;162(3):79–112. https://doi.org/10.1093/ibd/izac015.127
Palsson OS, Whitehead WE, van Tilburg MA, Chang L, Chey W, Crowell MD, et al. Rome IV diagnostic questionnaires and tables for investigators and clinicians. Gastroenterology. 2016;150(6):1481–1491. Epub ahead of print. https://doi.org/10.1053/j.gastro.2016.02.014
Kulyk A, Shafer LA, Graff LA, Stone J, Witges K, Targownik LE, et al. Urgency for bowel movements is a highly discriminatory symptom of active disease in persons with IBD (the Manitoba Living with IBD study). Aliment Pharmacol Ther. 2022;56(11‐12):1570–1580. https://doi.org/10.1111/apt.17241
Wang C, Ishizuka T, Tanaka M, Matsuo K, Knight H, Harvey N, et al. Bowel urgency in patients with ulcerative colitis and Crohn's disease: a cross‐sectional real‐world survey in Japan. Adv Ther. 2024;41(1):431–450. https://doi.org/10.1007/s12325‐023‐02726‐4
Rangan V, Mitsuhashi S, Singh P, Ballou S, Hirsch W, Sommers T, et al. Risk factors for fecal urgency among individuals with and without diarrhea, based on data from the national health and nutrition examination survey. Clin Gastroenterol Hepatol. 2018;16(9):1450–1458. https://doi.org/10.1016/j.cgh.2018.02.020
Dubinsky MC, Clemow DB, Hunter GT, Li X, Vermeire S, Hisamatsu T, et al. Clinical effect of Mirikizumab treatment on bowel urgency in patients with moderately to severely active ulcerative colitis and the clinical relevance of bowel urgency improvement for disease remission. Crohns Colitis 360. 2023;5(1):otac044. https://doi.org/10.1093/crocol/otac044
Ghosh S, Mitchell R. Impact of inflammatory bowel disease on quality of life: results of the European Federation of Crohn's and Ulcerative Colitis Associations (EFCCA) patient survey. J Crohns Colitis. 2007;1(1):10–20. https://doi.org/10.1016/j.crohns.2007.06.005
Mitchell R, Kremer A, Westwood N, Younge L, Ghosh S. Talking about life and IBD: a paradigm for improving patient‐physician communication. J Crohns Colitis. 2009;3(1):1–3. https://doi.org/10.1016/j.crohns.2008.07.002
Rockwood TH, Church JM, Fleshman JW, Kane RL, Mavrantonis C, Thorson AG, et al. Fecal incontinence quality of life scale: quality of life instrument for patients with fecal incontinence. Dis Colon Rectum. 2000;43(1):9–16. https://doi.org/10.1007/bf02237236
Halpin SJ, Ford AC. Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta‐analysis. Am J Gastroenterol. 2012;107(10):1474–1482. https://doi.org/10.1038/ajg.2012.260
Simrén M, Palsson OS, Heymen S, Bajor A, Törnblom H, Whitehead WE. Fecal incontinence in irritable bowel syndrome: prevalence and associated factors in Swedish and American patients. Neuro Gastroenterol Motil. 2017;29(2). https://doi.org/10.1111/nmo.12919